Exemptia 20mg/0.4ml Injection
Prescription Required
Product introduction
Exemptia 20mg/0.4ml Injection is a medicine used to treat a variety of conditions such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn’s disease. It provides relief from swelling, pain, and redness associated with various disorders and improves physical function.
Exemptia 20mg/0.4ml Injection is used to treat joint diseases leading to severe painful swelling and redness of the joints that can lead to difficulty in movement.
Exemptia 20mg/0.4ml Injection is used to treat joint diseases leading to severe painful swelling and redness of the joints that can lead to difficulty in movement.
Uses of Exemptia Injection
Benefits of Exemptia Injection
In Ankylosing spondylitis
Ankylosing spondylitis is a rare type of arthritis that affects the spine or larger joints. It usually starts in your lower back and can spread up to your neck or damage joints in other parts of your body. Exemptia 20mg/0.4ml Injection helps reduce pain, stiffness and swelling in your spine and joints. It helps improve flexibility and prevents disease progression. This will help you lead a better and active life.
In Rheumatoid arthritis
Exemptia 20mg/0.4ml Injection reduces pain, stiffness, and swelling in your joints and slows down the progression of bone and joint damage. This will help you do normal daily activities more easily and thus improve your quality of life. The medicine is given as an injection is given by a doctor or nurse and should not be self-administered.
In Psoriasis
Psoriasis is a condition where the skin cells in the body grow too quickly and form scales and dry patches. They can grow anywhere, but most appear on the scalp, elbows, knees, and lower back. Exemptia 20mg/0.4ml Injection reduces the scaly, itchy patches which may develop on the different parts of the body. It may take several months to become fully effective. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
In Ulcerative colitis
Ulcerative colitis is a disease of the large intestine (colon) and rectum in which the lining of the bowel becomes red and swollen. This can lead to bleeding, frequent diarrhea and abdominal pain. It relieves these symptoms and also helps you to stay well by preventing them from coming back. You should drink plenty of fluids while taking on treatment with this medicine to make sure you stay hydrated.
In Crohn’s disease
Crohn’s disease is a chronic (long-term) inflammatory disease of the intestines. The most common symptoms are diarrhea and pain in your abdomen. Exemptia 20mg/0.4ml Injection helps reduce the inflammation, relieve the symptoms, and prevent them from coming back.
Side effects of Exemptia Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Exemptia
- Headache
- Sinus inflammation
- Rash
- Upper respiratory tract infection
- Injection site reaction
How to use Exemptia Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
SAFE
Consuming alcohol with Exemptia 20mg/0.4ml Injection does not cause any harmful side effects.
Pregnancy
SAFE IF PRESCRIBED
Exemptia 20mg/0.4ml Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
SAFE IF PRESCRIBED
Exemptia 20mg/0.4ml Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Exemptia 20mg/0.4ml Injection may cause side effects which could affect your ability to drive.
Exemptia 20mg/0.4ml Injection may cause room spinning sensation and vision disturbances. This may affect your driving ability.
Exemptia 20mg/0.4ml Injection may cause room spinning sensation and vision disturbances. This may affect your driving ability.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Exemptia 20mg/0.4ml Injection in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Exemptia 20mg/0.4ml Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- It is given by injection under the skin (via subcutaneous).
- Take it as per the dose and duration suggested by the doctor.
- Inform your doctor immediately if you notice severe rash, hives, swelling of hands or face and shortness of breath.
- Store the pen in the refrigerator. When refrigeration is not possible, you can also keep your pen at room temperature (less than 30°C) for up to 2 weeks. Do not freeze it.
- Do not stop taking the medication suddenly without talking to your doctor first.
Fact Box
Chemical Class
Monoclonal antibody (mAb)
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Disease Modifying Anti-Rheumatoid Drugs (DMARDs)- Biologics
Patient concerns
User feedback
Patients taking Exemptia 20mg/0.4ml Injection
Once A Month
73%
Twice A Month
27%
What are you using Exemptia Injection for?
Rheumatoid ar*
50%
Crohn’s disea*
17%
Others
17%
Ulcerative co*
17%
*Rheumatoid arthritis, Crohn’s disease, Ulcerative colitis
How much was the improvement?
Average
100%
What were the side-effects while using Exemptia 20mg/0.4ml Injection?
No Side Effec*
100%
*No Side Effect
FAQs
What type of drug is Exemptia 20mg/0.4ml Injection?
Exemptia 20mg/0.4ml Injection belongs to a class of drugs name TNF blockers. It reduces joint damage by reducing swelling and improves joint function.
What benefit can you expect from your treatment with Exemptia 20mg/0.4ml Injection?
You may notice a lessening of joint swelling, pain, and stiffness, often within the first 8 weeks of starting the treatment.
Can Exemptia 20mg/0.4ml Injection weaken your immune system?
Exemptia 20mg/0.4ml Injection is a TNF blocker medicine that can lower the ability of your immune system to fight infections. Inform your doctor if you have been suffering from any infections before taking this medicine.
Can Exemptia 20mg/0.4ml Injection be used with other arthritis medicines?
Exemptia 20mg/0.4ml Injection is a biological disease-modifying antirheumatic drug (bDMARD) and may be used with other medicines like methotrexate (DMARDs); prednisolone (steroid); naproxen or ibuprofen (anti-inflammatory medicines) and paracetamol (pain killers). However, it cannot be used with other bDMARDs. Your doctor will be able to give you more information on this.
Should Exemptia 20mg/0.4ml Injection be stopped before any surgery?
Yes, treatment with this medicine should be stopped before surgery. It can start again after the operation at a time decided by your surgeon and rheumatologist (often once the wound has healed and there is no infection).
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 633.
- Wallace JL, Sharkey KA. Pharmacotherapy of Inflammatory Bowel Disease. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1359.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 22-24.
- Adalimumab. North Chicago, Illinois: Abbott Laboratories; 2002 [revised Jan. 2008]. [Accessed 25 Jan. 2019] (online) Available from:
- Adalimumab. North Chicago, Illinois: AbbVie Inc.; 2002 [revised May 2014]. [Accessed 02 Apr. 2019] (online) Available from:
Marketer details
Name: Zydus Cadila
Address: Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
65 people viewed this recentlyMRP
₹25000
Inclusive of all taxes
1.0 ml in 1 prefilled syringe
SOLD OUT